Wixela Inhub 250 ug/1 250 ug/1 POWDER

Wixela Inhub 250 ug/1

Active Ingredient:
fluticasone propionate and salmeterol
Form:
POWDER
Brand:
Wixela Inhub
Origin:
USA

Buy Wixela Inhub 250 ug/1 fluticasone propionate and salmeterol

Wixela Inhub 250 ug/1 is a combination of fluticasone propionate and salmeterol, designed for respiratory use. This powder inhaler is used to manage asthma symptoms and improve breathing. It contains 60 doses per inhaler.

Strength

250 ug/1

Pack Size

1 INHALER in 1 CARTON (0378-9321-32) / 60 POWDER in 1 INHALER

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Wixela Inhub 250 ug/1 is primarily used for the maintenance treatment of asthma in adults and children. It helps to control and prevent asthma symptoms by reducing inflammation and opening airways. This medication is not intended for immediate relief of acute asthma attacks.

Side Effects

  • Common effects of Wixela Inhub 250 ug/1 may include throat irritation, hoarseness, and coughing. Some users might experience headaches or tremors. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Wixela Inhub 250 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential allergic reactions and discontinue use if severe side effects occur. Regular monitoring may be required for long-term use.

Avoid Interactions

  • Wixela Inhub 250 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other respiratory medications should be used with caution.

References

Frequently Asked Questions

Wixela Inhub 250 ug/1 is used for the maintenance treatment of asthma to control and prevent symptoms.

Wixela Inhub 250 ug/1 is administered via inhalation. Follow the instructions provided by your healthcare professional for proper use.

Common side effects may include throat irritation, hoarseness, coughing, headaches, and tremors.

No, Wixela Inhub 250 ug/1 is not intended for immediate relief of acute asthma attacks.

Follow the prescribed dosage and administration instructions. Be aware of potential allergic reactions and discontinue use if severe side effects occur.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT